Search
Baiyunshan Subsidiary Tianxin Pharmaceutical's Ceftazidime Injection Successfully Passes National Consistency Evaluation
3 week ago /
Read about 0 minute
Author：小编
The holding subsidiary of Baiyunshan, Tianxin Pharmaceutical, has announced that its Ceftazidime for Injection (available in strengths of 0.5g and 1.0g) has successfully passed the National Medical Products Administration's rigorous consistency evaluation for the quality and efficacy of generic drugs. This achievement marks the approval of the product.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
